Patients with Untreated Obstructive Sleep Apnea Have an 82% AFib Recurrence Rate After Cardioversion. Diagnosis and Treatment of OSA is Associated with Lower Recurrence of AFib.1

The 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement recommends screening for sleep apnea when evaluating patients for AFib ablation.2

Total Sleep Solutions is a comprehensive patient care pathway that expands the reach of sleep services to optimize outcomes in cardiovascular patients with sleep apnea.

For more information about Total Sleep Solutions or the WatchPATTM Family of Products, please complete the form below and an Itamar MedicalTM representative will contact you.

Total Sleep Solutions

Mouse over each icon for a description.

More than 50% of cardiovascular patients remain undiagnosed or treated for sleep apnea. A simple questionnaire can help you identify patients who may be at risk for sleep apnea, making them eligible for a diagnostic sleep test.
To be eligible for insurance coverage for sleep apnea therapy, your patients need a validated diagnosis. Diagnosis is obtained with an easy to use sleep study, performed at the patient’s home.
Adequately treated sleep apnea has been associated with improved cardiovascular outcomes and lower rates of hospital readmission.
The success of sleep apnea therapy depends on patients’ compliance. Compliance to therapy should be optimized to improve cardiovascular outcomes. Your patients will benefit from your staying informed and updated on their progress.
- No Return Shipment
- No Cleaning or Charging
- Immediate Access to Sleep Data for Interpretation
- Central Sleep Apnea Identification
WatchPAT 300
- Intuitive Design for Improved Patient Comfort
- Improved Workflow with One Stop Processing
- 15 Second Rapid Data Download
- Central Sleep Apnea Identification

Please check with the payer’s policies. Your information will be handled in accordance with our privacy policy.


1. Obstructive Sleep Apnea and the Recurrence of Atrial Fibrillation. Circulation, Kanagala, R. (2003).

2. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary, Europace (2018) 20, 157–208